FindTrial
Sign In

A study on the prior administration of simethicone on the quality of visual field in upper gastrointestinal endoscopy in pediatric patients: A prospective, double-blind, randomized, parallel controlled trial

A study on the prior administration of simethicone on the quality of visual field in upper gastrointestinal endoscopy in pediatric patients: A prospective, double-blind, randomized, parallel controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15005804
Enrollment
Unknown
Registered
2015-01-09
Start date
2015-06-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premedicaton for upper GI endoscopy

Interventions

1:Oral lidocaine hydrochloride mucilage (1ml/ year old) before 5 min of gastroscopy
2:Oral simethicone (10 mL) before 20 min of gastroscopy and oral lidocaine hydrochloride mucilage (1ml/ year old) before 5 min of gastroscopy
3:Oral simethicone (10 mL) before 30 min of gastroscopy and oral lidocaine hydrochloride mucilage (1ml/ year old) before 5 min of gastroscopy

Sponsors

Children's Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Appropriately indicated for upper GI endoscopy; 2. Age 6-18, male or female; 3. Informed consent obtained from parent/guardian; 4. Successful completion of procedure.

Exclusion criteria

Exclusion criteria: 1. Endoscopy contraindicated; 2. Contraindication for administration of lidocaine and/or simethicone

Design outcomes

Primary

MeasureTime frame
Bubble removal rate;View definition;—

Countries

China

Contacts

Public ContactYing Huang
yhuang815@163.com+86 13816882247

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026